Whey Finance

Global Generics Industry Almanac 2021: $ 348.3 Billion Revenue in 2020 – Market Summary, Competitive Analysis and Forecast to 2025


DUBLIN, September 02, 2021– (BUSINESS WIRE) – The report “Generics Global Industry Almanac – Market Summary, Competitive Analysis and Forecast to 2025″ has been added to ResearchAndMarkets.com offer.

The global generics market achieved a total revenue of $ 348.3 billion in 2020, representing a compound annual growth rate (CAGR) of 5.1% between 2016 and 2020.

The Global Generic Acid industry profile provides leading qualitative and quantitative summary information including: market size (2016-20 value and volume, and forecast to 2025). The profile also contains descriptions of the major players, including key financial indicators and an analysis of competitive pressures in the market.

Highlights

  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents which have now expired. Unbranded generics and all branded generics are included. However, off-patent drugs which continue to be offered by the original manufacturer under the original name and which are part of the “generically eligible” market are not included.

  • Market value is assessed at ex-works prices.

  • Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region that is represented by generic drugs. It is therefore a measure of the penetration rate of generics, and not an absolute measure of the volume of the market.

  • Regional volumes are calculated as weighted averages of the countries that make up the region in question for which volume data exists.

  • Note that all “1” (one) or 100% volumes are due to rounding, as the publisher does not believe generics will ever fully represent 100% of the drug market in any country or region.

  • All market data and forecasts are represented in nominal terms (i.e. without adjustment for inflation) and all currency conversions used in creating this report have been calculated using average exchange rates constant annuals of 2020.

  • The forecast figures presented in this report are calculated using stress scenarios for the market. The duration of the pandemic and the restrictions introduced by various countries are still difficult to predict. Many governments had introduced national lockdowns and temporarily banned the sale of products deemed “non-essential”. As the duration of the pandemic and its impact on this market are uncertain, the data used in this report has been modeled taking into account the expected impacts on the national economy.

  • The market consumption volume increased with a CAGR of 2.2% between 2016 and 2020, reaching a total of 68.0% in 2020.

  • Historically, growth has been strongest in the Asia-Pacific and Europe regions and has been moderate in the United States.

Scope

  • Save time conducting entry-level research by identifying the size, growth, and major players in the Global Generics Market

  • Use the Five Forces Analysis to determine the competitive intensity and hence the attractiveness of the Global Generics Market

  • Key Company Profiles Reveal Global Operation Details and Financial Performance of Major Generics Market Players

  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five-year forecast in value and volume

Reasons to buy

  • What was the size of the global generics market by value in 2020?

  • What will be the size of the global generics market in 2025?

  • What factors are affecting the strength of competition in the global generics market?

  • How has the market performed over the past five years?

  • How big is the global generics market relative to its regional counterparts?

Main topics covered:

1. Summary

1.1. Market value

1.2. Market value forecast

1.3. Market volume

1.4. Market volume forecast

1.5. Geographic segmentation

1.6. Competitive landscape

2 Presentation

2.1. What is this report about?

2.2. Who is the target reader?

2.3. How to use this report

2.4. Definitions

3 global generics

3.1. Market Snapshot

3.2. Market data

3.3. Market segmentation

3.4. Market outlook

3.5. Five forces analysis

3.6. Macroeconomic indicators

Companies mentioned

  • Pfizer Inc.

  • Servier Laboratories

  • STADA Arzneimittel AG

  • Aspen Pharmacare Holdings Ltd

  • EMS SA

  • Laboratories Eurofarma SA

  • Ache Laboratorios Farmaceuticos SA

  • Apotex, Inc.

  • China Grand Pharmaceutical and Healthcare Holdings Limited

  • Lupine Ltd.

  • Cipla Limited

  • PT Kalbe Farma Tbk

  • PT Sanbe Farma

  • PT Soho Global Health Tbk

  • PT Indofarma (Persero), Tbk

  • Viatris inc.

  • Daiichi Sankyo Co Ltd

  • Sawai Pharmaceutical Co Ltd

  • Sun Pharmaceutical Industries Ltd

  • Aurobindo Pharma SA

  • Krka, dd, Novo mesto

  • Sanofi SA

  • Abbott Laboratories

  • Adcock Ingram Holdings Ltd

  • Yuhan Corp

  • Teva Pharmaceutical Industries Limited

  • Esteve Group

  • Deva Holding AS

  • Abdi Ibrahim Ilac Sanayi ve Ticaret AS

  • Nobelpharma Co Ltd

For more information on this report, visit https://www.researchandmarkets.com/r/ucdpb

View the source version on businesswire.com: https://www.businesswire.com/news/home/20210902005391/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Director
[email protected]
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900